Demographic and clinical characteristics |
|
|
|
Mean age, years ± SD |
65.3 ± 15.4 |
71.4 ± 14.0 |
0.47 |
Men, n (%) |
160 (65.0%) |
83 (58.0%) |
0.21 |
Hypertension, n (%) |
115 (46.5%) |
88 (61.9%) |
0.003 |
Diabetes, n (%) |
32 (12.9%) |
32 (22.5%) |
0.01 |
Ischemic cardiovascular diseases, n (%) |
29 (11.7%) |
31 (21.8%) |
0.007 |
VTE, n (%) |
4 (1.6%) |
3 (2.1%) |
0.72 |
COPD, n (%) |
20 (8.0%) |
10 (7.0%) |
0.70 |
Laboratory and clinical results during hospitalization |
|
|
|
Mean D-dimers, ng/ml ± SD |
3585.0 ± 7172.2 |
1748.1 ± 3417.5 |
0.02 |
Mean C-reactive protein, mg/L ± SD |
93.2 ± 77.6 |
74.1 ± 67.4 |
0.07 |
Mean leukocytes, cell/mmc ± SD |
6943.5 ± 3187.4 |
8811.2 ± 3767.4 |
0.001 |
Mean PaO2/FiO2, ratio ± SD |
292.2 ± 84.6 |
284.1 ± 77.6 |
0.16 |
Time from symptoms to D-dimer measurement, days ± SD |
7.2 ± 4.0 |
4.9 ± 4.2 |
< 0.001 |
qCSI, mean ± SD |
2.1 ± 3.3 |
4.4 ± 4.3 |
< 0.001 |
Deaths, n (%) |
39 (15.7%) |
20 (14.0%) |
0.65 |
Hospital length in subject who died, days ± SD |
14.5 ± 11.4 |
16.2 ± 14.3 |
0.30 |
Pre-admission therapy |
|
|
|
Anticoagulant, n (%) |
14 (5.6%) |
60 (42.2%) |
< 0.00001 |
Steroids, n (%) |
7 (2.8%) |
54 (38.0%) |
< 0.00001 |
Anticoagulant AND steroids, n (%) |
2 (0.8%) |
31 (21.8%) |
< 0.00001 |
Anticoagulant OR steroid, n (%) |
19 (7.7%) |
83 (58.4%) |
< 0.00001 |